Eoflow Co Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Eoflow Co., Ltd. is a South Korean medical device company specializing in the development and production of wearable drug delivery systems, with a focus on insulin delivery for diabetes management. The company’s primary product is a compact, wearable insulin pump designed to provide continuous and precise insulin administration, supporting the needs of individuals with diabetes. Eoflow leverages advanced microfluidic and electrochemical technology to enhance device functionality and user convenience. The company is headquartered in Seongnam, South Korea, and its shares are listed on the KOSDAQ.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
294090
Country
🇰🇷 South Korea